Related Experiment Video
Updated: Jun 14, 2026
09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Breaking down the barriers: siRNA delivery and endosome escape
Monika Dominska1, Derek M Dykxhoorn
1Dr John T Macdonald Foundation Department of Human Genetics, John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, 1501 NW 10 Ave, Miami, FL 33136, USA.
Journal of Cell Science
|April 2, 2010
Summary
RNA interference (RNAi) therapies use small interfering (si)RNAs to silence disease genes. This commentary explores strategies to improve siRNA delivery by enhancing endosomal escape for greater therapeutic efficacy.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- RNA interference (RNAi) offers targeted gene silencing for disease treatment.
- Effective delivery of small interfering (si)RNAs (siRNAs) to the cytoplasm is crucial for therapeutic applications.
- Current siRNA delivery methods often struggle with intracellular trafficking, particularly endosomal escape.
Purpose of the Study:
- To review and highlight novel strategies for enhancing siRNA endosomal escape.
- To discuss approaches that improve the efficiency of siRNA-mediated gene silencing.
Main Methods:
- Focuses on reviewing recent advancements in siRNA delivery technologies.
- Highlights strategies specifically designed to overcome endosomal entrapment.
- Discusses the importance of intracellular trafficking for siRNA function.
Main Results:
- Progress has been made in developing cell-targeting reagents for siRNA delivery.
- Endosomal escape remains a significant hurdle for many siRNA delivery systems.
- Novel strategies show promise in facilitating cytoplasmic access for siRNAs.
Conclusions:
- Enhancing endosomal escape is critical for improving the efficacy of siRNA-based therapeutics.
- Further development of delivery systems that promote cytoplasmic trafficking is needed.
- Optimized delivery strategies will increase the potential of siRNA technology in medicine.
More Related Videos
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:34Directing Proteins to the Rough Endoplasmic Reticulum
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:20Receptor-mediated Endocytosis
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...